VANCOUVER, BC--(Marketwired - Feb 1, 2016) - Breathtec Biomedical Inc. (CNSX: BTH) (CSE: BTH) (the "Company" or "Breathtec"), a medical diagnostics company focused on developing, in-licensing and commercializing proprietary, innovative and best-in-class breath analysis devices for the early detection of life threatening diseases, is pleased to announce that the Company expects to start trading on the Canadian Securities Exchange (the "Exchange") on Monday, February 1, 2016 under the symbol "BTH".